BCKDE1A Antibodies

Santa Cruz Biotechnology delivers a wide array of BCKDE1A monoclonal antibodies for research applications. BCKDE1A monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BCKDE1A, or branched-chain keto acid dehydrogenase E1 alpha, plays a crucial role in the metabolism of branched-chain amino acids, which are essential for protein synthesis and energy production. BCKDE1A maintains metabolic homeostasis and has implications in various metabolic disorders. Research focused on BCKDE1A contributes to understanding metabolic diseases and developing potential therapeutic strategies. BCKDE1A monoclonal antibodies enable precise detection and analysis of BCKDE1A expression patterns across different tissues and experimental conditions. Studying BCKDE1A helps reveal its regulatory mechanisms and metabolic pathways in cellular processes. BCKDE1A monoclonal antibodies support cutting-edge metabolic research, advancing scientific knowledge and potential therapeutic developments within the research community.